HDAC抑制剂Domatinostat促进Merkel细胞癌细胞周期停滞、诱导凋亡并增强免疫原性
Merkel细胞癌(MCC)是一种罕见高侵袭性皮肤癌,免疫检查点抑制剂可使部分患者获得显著缓解,但原发或继发耐药仍限制获益。本研究报道Domatinostat(靶向HDAC I类的口服小分子抑制剂)在MCC中的临床前数据:单细胞RNA测序显示抗原加工与呈递、细胞周期停滞及凋亡执行期基因表达特征;功能实验证实其诱导G2M期停滞和凋亡,并在存活细胞中上调抗原加工机器基因转录和翻译,增加MHC I类表面表达,恢复存活MCC细胞对细胞毒性T细胞识别和清除的敏感性。
要点
- Domatinostat诱导MCC细胞G2M期停滞和凋亡。
- Domatinostat上调存活MCC细胞抗原加工机器基因并增加MHC I类表面表达。
- Domatinostat恢复存活MCC细胞对同源细胞毒性T细胞识别和清除的敏感性。
核心结论
- Domatinostat不仅发挥直接抗肿瘤效应,还恢复MCC细胞HLA I类表面表达,从而恢复存活MCC细胞对同源细胞毒性T细胞识别和清除的敏感性。
研究设计与样本
- 临床前研究,采用单细胞RNA测序和功能实验评估Domatinostat在MCC中的作用及机制。
主要发现
- 单细胞RNA测序显示治疗后有抗原加工与呈递、细胞周期停滞和凋亡执行期的独特基因表达特征。
- 功能实验显示Domatinostat诱导G2M期停滞和凋亡。
- 在存活细胞中,抗原加工机器组分基因转录和翻译上调,导致MHC I类表面表达增加。
临床怎么用
- Domatinostat目前正在临床评估中用于克服免疫治疗耐药。
- 其通过恢复HLA I类表面表达可能增强MCC对细胞毒性T细胞识别的敏感性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Merkel cell carcinoma (MCC) is a rare, highly aggressive skin cancer for which immune modulation by immune checkpoint inhibitors shows remarkable response rates. However, primary or secondary resistance to immunotherapy prevents benefits in a significant proportion of patients. For MCC, one immune escape mechanism is insufficient for recognition by T cells owing to the downregulation of major histocompatibility complex I surface expression. Histone deacetylase inhibitors have been demonstrated to epigenetically reverse the low major histocompatibility complex I expression caused by the downregulation of the antigen-processing machinery. Domatinostat, an orally available small-molecule inhibitor targeting histone deacetylase class I, is currently in clinical evaluation to overcome resistance to immunotherapy. In this study, we present preclinical data on domatinostat's efficacy and mode of action in MCC. Single-cell RNA sequencing revealed a distinct gene expression signature of antigen processing and presentation, cell-cycle arrest, and execution phase of apoptosis on treatment. Accordingly, functional assays showed that domatinostat induced G2M arrest and apoptosis. In the surviving cells, antigen-processing machinery component gene transcription and translation were upregulated, consequently resulting in increased major histocompatibility complex I surface expression. Altogether, domatinostat not only exerts direct antitumoral effects but also restores HLA class I surface expression on MCC cells, therefore, restoring surviving MCC cells' susceptibility to recognition and elimination by cognate cytotoxic T cells.
引用
- Song L, Bretz AC, Gravemeyer J, et al. The HDAC Inhibitor Domatinostat Promotes Cell-Cycle Arrest, Induces Apoptosis, and Increases Immunogenicity of Merkel Cell Carcinoma Cells. J Invest Dermatol. 2020. PMID: 33002502. doi:10.1016/j.jid.2020.08.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。